LI Lu-sheng, ZHAO Xin, CHI Liu-ying, et al
2007, 16(1): 34-36.
Objective To evaluate the diagnosis value of Endothelin (ET), Calcitonin gene-related peptide (CGRP) and theratio in diabetic nephropathy (DN).Methods To choose 54 healthy as the control group and 124 patients with diabetes or DN as test group.According to urinary albumin excretion rate (uAER), the test group was divided into three groups, which were diabetes group of normalalbuminuria (group A), early DN (group B) and clinical DN&renal failure group (group C).Plasma concentration of ET and CGRP were measured with radioimmunossay for those in the Control group and patients with diabetes or DN.Results The level of ET was significantly higher in diabetic nephropathy than that in the control group (P<0.01), and there was positive correlationbetween ET and uAER (r=0.591, P<0.01).The plasma level of CGRPwas significantly lower in diabetic nephropathy than that in the control group (P<0.01), and there was negative correlation between CGRP and uAER (r=-0.389, P<0.05).The level of ET, CGRP and ET/CGRP ratio have evidently changed with the uAER rised.Conclusion ①The level of ET, CGRP and type 2 diabetic nephropathy are closely related, and which probably plays a role in the development of DN.②ET/CGRP ratio, as a new way for diagnosis, can even more reflecte the seriousness of DN.③This experiment provide us a new way for the prevention and treatment of DN with extrinsic CGRP.